AliveCor experimental AI found to compare favorably to an ILR
This is significant considering that ILRs have been viewed as the industry gold standard, allowing for long-term surveillance of AFib.
AliveCor
AliveCor’s 6-lead ECG reader coming soon
More leads mean increased accuracy, which could potentially mean more lives saved.
AliveCor’s bloodless hyperkalemia test scores the “Breakthrough Device” designation from the FDA
This means that the agency will consider AliveCor's technology on an accelerated clearance track.
AliveCor launches Kardia Band, the first FDA-cleared medical accessory for Apple Watch
The company has also introduced the SmartRhythm feature that continuously monitors heart rate from the Apple Watch.
AliveCor, Mayo Clinic to use AI to help prevent sudden cardiac death
The two parties have teamed-up to develop tools for medical and non-medical personnel to easily screen for congenital long QT syndrome (LQTS) early.
AliveCor unveils AI-enabled, stroke-preventing platform for doctors, raises $30M
The platform is designed to help doctors monitor patients for the early detection of atrial fibrillation, which is the most common cardiac arrhythmia.
AliveCor updates its mobile app to manage top risk factors for stroke
Both iOS and Android versions combine ECG, body weight and blood pressure to improve overall heart health and lower the risk of cardiovascular disease.
Small study shows AliveCor’s smartphone ECG is as good as standard Holter monitor
The study involved patients already wearing the standard Holter ambulatory event monitor with AliveCor's device being added to the mix.
AliveCor to launch remote monitoring trial for AFib with Columbia University
The 300-patient randomized trial will test the effect of remote monitoring on atrial fibrillation (AF) using AliveCor's Kardia Mobile device.
AliveCor unveils Kardia Band for Apple Watch
Pending FDA's 510k clearance, the device provides caregivers the opportunity to take a more active role in helping their loved ones engage in their own care.